|
November 28, 2007
GeneraMedix Inc. receives FDA approval
for Epirubicin Hydrochloride Injection
August 9, 2007
GeneraMedix
Inc. Announces FDA Approval and Launch of Ampicillin and
Sulbactam for Injection, USP
August 8, 2007
GeneraMedix
Inc. launches Fosphenytoin Sodium Injection, USP
August 7, 2007
GeneraMedix
Inc. Announces FDA Approval and Launch of Three Generic
Injectable Products
June 29, 2007
GeneraMedix
Inc. receives FDA approval for Ampicillin and Sulbactam for
Injection, USP.
April 30,
2007
GeneraMedix Inc. receives FDA approval
for Methotrexate Injection, USP
April 26, 2007
GeneraMedix Inc. receives FDA approval for Fluorouracil Injection, USP
April 24, 2007
GeneraMedix
Inc. receives FDA approval for CARBOplatin Injection.
December
13, 2006
Hollister-Stier
Contract Manufacturing Enters Agreement with GeneraMedix
Inc.
August 31, 2006
Akorn, Inc. and GeneraMedix Inc. Sign Commercial Manufacturing
Supply Agreement
April 1, 2005
PRESS RELEASE - GeneraMedix Inc. Launches First
Products
March 2005
GeneraMedix Inc. prepares for first product launches in
late March, 2005. The products will be generic injectable
products for the hospital market.
February 2005
GeneraMedix Inc. moves to our new headquarters in Liberty
Corner, New Jersey. Our new corporate headquarters are
located at 150 Allen Road, Liberty Corner, NJ 07938. Our
toll-free remains the same, 1-866-GENERA-1 (1-866-436-3721).
July 2004
GeneraMedix Inc. is founded by Ronald F. Quadrel, President
and CEO. GeneraMedix is established as a privately held
corporation located in Somerset County, New Jersey, about
45 miles west of New York City and 70 miles northeast of
Philadelphia. The company establishes plans to become a
full-service pharmaceutical company offering high-quality
generic parenteral products to the hospital and specialty
markets.
|
